Neurology

FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome



Amifampridine (Firdapse) is approved for adults with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder characterized by muscle weakness.
FDA Approvals

Source link

Related posts

You Behind The Illness

Newsemia

Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson’s disease.

Newsemia

Patients with fibromyalgia reporting severe pain but low impact of the syndrome: clinical and pain-related cognitive features.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World